Psoriasis Clinical Trials in San Antonio

Showing 141-155 of 155 trials

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

NCT01465282

The purpose of this study is to evaluate the effectiveness of 3 dose strengths of CT327 ointment (0.05%, 0.1% and 0.05% w/w) compared to a placebo, when applied twice daily for up to 8 weeks, to the psoriatic plaques of patients with psoriasis vulgaris.

Psoriasis Vulgaris

Creabilis SA160 participantsStarted Dec 2011

Hotsprings, Arkansas, United States • San Ramon, California, United States • Bay City, Michigan, United States +10 more locations

COMPLETEDPhase 3< 1 mile

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00570986

The purpose of this study is to determine the safety and efficacy of 2 doses of ABT-874 versus placebo in the treatment of subjects with moderate to severe plaque psoriasis.

Plaque Psoriasis

AbbVie (prior sponsor, Abbott)1,465 participantsStarted Nov 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +113 more locations

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Psoriasis Trials in Other Cities

Open Label Continuation Study in Moderate to Severe Psoriasis

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

A Study for Adults With Plaque Psoriasis

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

An Exploratory Genetic Study in Participants With Psoriasis

Randomized Study of PH-10 for Psoriasis

Other Conditions in San Antonio